参会报名
会议介绍
会议日程
会议嘉宾
参会指南
手机下单

首页 > 商务会议 > 医疗医学会议 > BIOTEC-CHINA 2018生物技术大会更新时间：2018-09-05T09:57:03

收藏11人

分享到

BIOTEC-CHINA 2018生物技术大会已截止报名
推荐参加：2025（第十一届）中国国际骨科内植物与生物材料大会暨展览会

会议时间： 2018-09-21 08:00至 2018-09-22 18:00结束

会议地点：上海详细地址会前通知周边酒店预订

主办单位：上海广贸会展服务有限公司

行业热销热门关注看了又看换一换

会议介绍
会议内容主办方介绍

BIOTEC-CHINA 2018生物技术大会宣传图

展会简介：

BIOTEC-CHINA 展会立足生物技术全产业链，致力于搭建产业链上下游资源互补的合作与贸易平台，行业专业信息的集散平台和行业学术、技术的交流平台。BIOTEC-CHINA 将在全球范围内邀请参展企业与参观观众，将为每一位参展企业与采购商提供拓展海内外市场与了解全球行业前沿成果的绝好机会，为生物技术领域产学研用不同单位在不同发展阶段寻找最合适的合作伙伴。

展会日期：

2018年9月21-22日上海

开放时间（免费参观）：上午9:30至下午5:30

展品范围：

综合区域

基因组学

细胞培养

药物研究

测试/诊断设备，试剂

天然提取物

系统，软件，服务，数据库

生物集群，科技园区，投资，产业推广等

蛋白质组学

细胞生物学

生物成像设备

各种设备，耗材，试剂，阀门，泵

生物资源，生物材料（纳米材料/粒子）

生物安全，BCP，危机管理

再生医学/干细胞研究区

细胞培养，细胞生产服务

培养设备，搅拌器，培养基，试剂

会议日程（最终日程以会议现场为准）

初步议程

膝关节半月板生物力学与临床动态

陈鸿儒暨南大学附属第一医院骨科教授主任医师

Biomechanics of the knee joint meniscus and clinical dynamic

Hongru Chen professor, director of the physician Department orthopedic of the first affiliated hospital jinan university

工程纳米纤维细胞外基质（ECM）用于3D细胞培养和再生医学

任卫平韦恩州立大学骨科研究中心主任

Engineering nanofibrous extracellular matrix (ECM) for 3D cell culture and regenerative medicine

Weiping Ren, MD, PhDWayne State University /iBio Director of Orthopaedic Research

使用多价多功能纳米粒子进行埃博拉病毒/艾滋病毒感染的超灵敏生物传感和蛋白质 - 聚糖相互作用的解剖

周德建利兹大学纳米化学教授

Ultrasensitive Biosensing and Dissection of Protein-Glycan Interactions Underpinning the Ebola/HIV Infections Using Polyvalent Multifunctional Nanoparticles Dejian Zhou Professor of Nanochemistry University of Leeds

基于激光的微图案化和生物相容性聚合物的血管形成，用于改进组织工程支架

Hedieh Pazokian 光子学和量子技术研究学院

Laser-based micro-patterning and vascularization of biocompatible polymers for improved

tissue engineering scaffolds Hedieh Pazokian Photonics and quantum technologies research school

蛋白质在生物/纳米材料上的吸附

KOPAC Prof. Dr. Bülent Ecevit University

Adsorption on Bio/Nanomaterials Türkan KOPAC Prof. Dr. Bülent Ecevit University

评估皮质骨组织的各个象限的弹性模量和硬度：人体股骨的纳米压痕

Michael Zhuravkov白俄罗斯国立大学副教授

Assessment of elasticity modulus and hardness for various quadrants of cortical bone tissue: nanoindentation of human femur

Michael Zhuravkov Professor, Full Doctor Belarusian State University

基于分数阶微积分的细胞力学计算模型

Natalie Romanova 布里奇波特大学康涅狄格州美国

Computational Models of Cell Mechanics on basis of Fractional Calculus

Natalie Romanova University of Bridgeport, Connecticut, USA

利用弹性形状记忆材料实现医疗/保健用品/器械的自适应

黄为民新加坡南洋理工大学副教授

Elastic shape memory materials for self-comfort fitting of medical/health products/equipment

HUANG, Wei Min Nanyang Technological University Associate Prof.

金磁二氧化硅纳米复合物的制备与热效应研究

张莹沈阳药科大学副教授

Preparation and Thermal Effect Study of Magnetic Oxide-Gold Nanocomposites

Ying Zhang Shenyang Pharmaceutical University

3D打印人工骨研究

3D printing artificial bone research

杨龙贵州医科大学附属医院/贵州医科大学器官打印与生物制造中心

Long Yang Affiliated Hospital of Guizhou Medical University/Organic Printing and Biomanufacturing Center of Guizhou Medical University

快速愈合的钙基骨替代物的材料特性和临床表现

Jiin-Huey Chern Lin 生物材料研究中心主任, Cheng-Kung University

Material properties and clinical performance of a fast healing calcium-based bone substitute

Jiin-Huey Chern Lin Director of Center for Biomaterials Research, Cheng-Kung University

免疫细胞深度检测分析暨免疫状态量化评分体系的建立及应用

李先亮教授、硕士研究生导师首都医科大学附属北京朝阳医院

Establishment and application of immune cell depth detection analysis and immune status quantitative scoring system

Li Xianliang Beijing Chaoyang Hospital, Capital Medical University Professor

大鼠骨骼肌卫星细胞修复小鼠骨骼肌化学损伤的机理探讨

朱道立南通大学生命科学学院教授

Mechanism Discussion of rat skeletal muscle satellite cells repairing chemical damage of skeletal muscle in mice

Zhu Daoli Nantong university Professor of Life Sciences

临床用干细胞体外培养的原则与方法

李玉奎宁夏医科大学总医院干细胞研究所教授

Principles and methods for in vitro culture of clinical stem cells Yukui Li Ningxia Medical University General Hospital Professor of Stem Cell Research Institute

基于氰基丙烯酸酯材料的创新品种研发：可生物降解医用胶、肿瘤和透皮局部药物递送

徐亮中国人民解放军军事科学院军事医学研究院毒物药物研究所副研究员

Cyanoacrylate Based R&D: Biodegradable Medical Adhesive, Local Drug Delivery System For Cancer Treatment and for Transdermal Drug Delivery

Liang Xu State Key Laboratory of Toxicology and Medical Countermeasures Associate Professor

表没食子儿茶素没食子酸酯(EGCG)/明胶复合热交联材料的开发与骨再生领域的应用

黄安祺日本大阪齿科大学

The Development and Application in Bone Tissue Regeneration Medicine of Epigallocatechin Gallate-Modified Gelatin Sponges Treated by Vacuum Heating.

Huang Anqi Osaka Dental University

形状记忆聚合物材料及其4D打印在生物医学应用领域的发展及挑战

冷劲松哈尔滨工业大学教授专业学者特聘教授

Shape memory polymers and 4D printing: Development and challenges in biomedical applications Jinsong Leng Professor of Harbin Institute of Technology Changjiang Scholar Distinguished Professor

可血管化多孔陶瓷在治疗股骨头坏死中的作用及应用价值

卢建熙上海贝奥路生物材料有限公司总经理

The role and application value of vascularized porous ceramics in the treatment of femoral head necrosis

Lu Jianxi, CEO Shanghai Bio-lu Biomaterials Co., Ltd.

抗菌材料及其产品研究现状和发展

张维中国科学院理化技术研究所抗菌材料中心主任

Research status and development of antibacterial materials and their products

Wei Zhang Antibacterial Materials Center, Institute of Physics and Chemistry, Chinese Academy of Sciences director

何首乌中二苯乙烯苷诱导干细胞增殖与分化在心梗治疗中的作用研究

宋凡空军军医大学

The effect of THSG from Polygonum multiflorum on stem cells proliferation and differentiation for Myocardial Infarction treatment

Fan Song Air Force Medical University

脓毒症的细胞治疗

梁华平陆军军医大学教授

Cellular therapy for sepsis

Liang Hua-ping Army Military Medical University Professor

基于多能干细胞神经分化技术的细胞治疗和药物发现平台

范靖浙江霍德生物工程有限公司总经理兼技术总监

PLURIPOTENT STEM CELL DERIVED NEURONAL CELL PLATFORM FOR CELL THERAPY AND DRUG DISCOVERY

Jing Fan Hopstem Biotechnology Co., Ltd. CEO&CTO

玻尿酸在声带手术中的应用及临床需要

Application and clinical needs of hyaluronic acid in vocal cord surgery

张庆泉毓璜顶医院耳鼻喉科主任

Qingquan Zhang Director of Otolaryngology Department of Yuding Hospital

具有天然孔隙结构的植骨材料的研发及其在牙槽骨位点保留中的临床作用

唐志辉北京大学口腔医院第二门诊部主任

A biomimetic porous bone scaffold and its clinical effect on alveolar ridge preservation

Tang Zhihui Director of the second dental center of Peking University School and Hospital of Stomatology

多功能止血微球的制备及其在创面愈合中的应用

石长灿温州生物材料与工程研究所

Preparation of multifunctional hemostasis microspheres and its application in wound healing

Changcan Shi Wenzhou Institute of Biomaterials and Engineering

（更多嘉宾在确认中，最终议程，以现场会刊为准）

会议嘉宾（最终出席嘉宾以会议现场为准）

DMG Deutsche Malaria GmbH

Deutsche Malaria总部位于德国上海友好城市汉堡市。它是一家由企业和个人投资者资助的私人公司。

该公司已聚集来自德国，东南亚和非洲的杰出科学家，研究人员和顶级医疗机构开发出一种新的安全的疟疾疗法。它被称为fosmidomycin，与其他抗疟药联合使用，是一种高效，耐药性良好且安全的治疗方法。它也可以在严重疟疾的初始治疗中发挥作用。

最初由2015年诺贝尔奖获得者屠呦呦开发的青蒿素疗法由于疟疾寄生虫的耐药性而变得不那么有效。这是一个值得关注的问题。由于fosmidomycin与青蒿素衍生物不具有交叉耐药性，因此它可能在青蒿素失去其有效性的地区发挥重要作用。

因此，由Deutsche Malaria开创的项目可能非常适合与中国机构和公司进行科学和商业合作，为抗击疟疾带来新的，强大的和安全的解决方案。Deutsche Malaria非常有兴趣与合作伙伴一起实现这些项目。其中一些项目旨在打击非洲的疟疾，并可迅速实施。

中国对非洲的发展有着浓厚的兴趣，正如9月初中非合作论坛在北京所展示的那样，习近平主席宣布向非洲国家提供600亿美元的支持。

健康是改善生活质量的最重要问题之一。每年有2亿多人患有疟疾。每年近500,000死亡人数中约有80％是非洲儿童。这是非常令人担忧和不可接受的，但这种现象可以改变。与此同时，非常需要为非洲商务旅行者或游客提供新的有效疗法。

Deutsche Malaria有良好的解决方案，并正在BIOTEC-CHINA 2018年会上寻求对话和合作。

Deutsche Malaria CEO Dr David BA Hutchinson 受邀出席BIOTEC-CHINA 2018年年会并做大会主旨报告，报告题目：用fosmidomycin联合疗法应对青蒿素抗药性的挑战。一种治疗疟疾的并对儿童安全的全新疗法。

DMG Deutsche Malaria GmbH

Deutsche Malaria is based in Hamburg, the German partner city of Shanghai. It is a privately owned company financed by corporate and individual investors.

company has commanded outstanding scientists, researchers and top medical institutions in Germany, SE Asia and Africa to develop a new and safe therapy against malaria. It is called fosmidomycin and is administered in combination with other antimalarials as a highly effective, well tolerated and safe treatment. It may also have a role in the initial treatment of severe malaria.

The artemisinin therapies first developed by Tu Youyou, Nobel Laureate of 2015, are becoming less effective due to resistant malaria parasites. This is a matter of considerable concern. As fosmidomycin is not cross-resistant with the artemisinin derivatives, it could play an important role in areas where artemisinin is losing its effectiveness.

Hence projects being pioneered by Deutsche Malaria maybe very well positioned for scientific and commercial cooperation with Chinese institutions and companies to bring new, powerful and safe solutions to fight malaria. Deutsche Malaria is very interested to join with partners to bring these projects to fruition. A number of these projects are aimed at fighting malaria in Africa and could be quickly implemented.

China has a high interest in the development of Africa as was shown on the Forum of China-Africa Cooperation at the beginning of September in Beijing, where President Xi Jinping announced US $ 60 billion in support for African countries.

Health is one of the most important issues to improve the quality of life. More than 200 million people fall ill with malaria each year. About 80% of the nearly 500,000 deaths each year are African children. This is very concerning and unacceptable but it can be changed. At the same time, new and effective therapies for travellers to Africa on business or as tourists are much needed.

Deutsche Malaria has solutions and is looking for dialogue and partnerships at the BIOTEC-CHINA 2018 conference.

Deutsche Malaria CEO Dr David BA Hutchinson has been invited as the keynote speaker in the conference and the speech title is Meeting the challenge of artemisinin resistance with fosmidomycin combination therapy. A novel approach with safety in children at the forefront